Pyxis Oncology Inc (PYXS)

Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.15	-	-	-	-
Cost Of Revenue	0.475	-	-	-	-
Gross Profit	15.67	-	-	-	-
Operating Expenses	19.75% 21.28	17.77	25.35	18.12	20.95
Benefits Costs and Expenses	19.40	-	-	-	-
Costs And Expenses	19.40	-	-	-	-
Operating Income/Loss	68.45% -5.605	-17.77	-25.35	-18.12	-20.95
Nonoperating Income/Loss	8.25% 2.349	2.17	2.305	2.22	1.711
Income/Loss From Continuing Operations Before Tax	79.12% -3.256	-15.60	-23.05	-15.90	-19.24
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	79.12% -3.256	-15.60	-23.05	-15.90	-19.24
Net Income/Loss	79.12% -3.256	-15.60	-23.05	-15.90	-19.24
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,263% 51.29	1.5252	41.33	38.39	35.35
Diluted Average Shares	3,263% 51.29	1.5252	41.33	38.39	35.35
Basic Earnings Per Share	81.82% -0.06	-0.33	-0.56	-0.41	-0.54
Diluted Earnings Per Share	81.82% -0.06	-0.33	-0.56	-0.41	-0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-